It has been a mixed year for Shuttle Pharmaceuticals Holdings, Inc. insiders: $182,000 bought by one person and $505,000 sold by one, so more selling than buying overall.
HRT FINANCIAL LP (10% Owner) made the biggest buy, worth around $89,000.
Quarter by quarter: Last full quarter: net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 82,116 | $4.48 | $368K | SEC |
| Jul 15, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 1,033 | $4.67 | $5K | SEC |
| Jul 13, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 731 | $3.11 | $2K | SEC |
| Jul 13, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 8,266 | $3.38 | $28K | SEC |
| Jul 9, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 18,531 | $3.52 | $65K | SEC |
| Jul 9, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 10,580 | $3.33 | $35K | SEC |
| Jul 7, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 7,851 | $3.54 | $28K | SEC |
| Jul 7, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 9,022 | $3.51 | $32K | SEC |
| Jul 2, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 3,959 | $3.30 | $13K | SEC |
| Jul 1, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 25,836 | $3.44 | $89K | SEC |
| Jul 1, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 6,755 | $3.23 | $22K | SEC |
| Mar 14, 2024 | Senanayake Chris | Director | Sell | 1,626 | $1.61 | $3K | SEC |
| Jan 2, 2024 | Brown Milton | Director | Sell | 2,921 | $0.46 | $1K | SEC |
| Dec 20, 2023 | Jacobs Bette | Director | Sell | 4,157 | $0.46 | $2K | SEC |
| Jan 9, 2023 | Richards Steven M | Director | Sell | 995 | $1.61 | $2K | SEC |
In the last 12 months Shuttle Pharmaceuticals Holdings, Inc. insiders made open-market purchases worth about $182,000 and sales worth about $505,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in SHPH was filed on 2026-07-15.
No congressional trades in SHPH were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).